It’s February and the frozen snow that coated the asphalt in January has melted, the conditions have been safe and the open road is calling. OK, maybe the winter weather in New England isn’t your idea of a cyclists dream but that doesn’t mean that your eyes can’t be on our cycling prize.
I’ve been thinking a lot lately about that prize. Our Boston Brain Tumor Ride mantra is pedaling to turn progress into promise and it is the promise that is the prize we are all working towards. The progress that the NBTS has been making happen is remarkable and the promise of new treatments is real and material. Here are a few local highlights:
Dana Farber Cancer Institute
Anti-angiogenic gene therapy for brain tumors
Establishment of a consortium based tissue bank dedicated to Pediatric LGA
Brigham and Women’s Hospital
Defining micro RNA signaling in malignant gliomas.
GM3 as a novel aptoptosis inducing agent for human gliomas
Massachusetts General Hospital
Identification and characterization of novel genetic drivers of glioblastoma
Dendritic cells, onocolytic hsv, and brain tumor immunotherapy
Children’s Hospital Boston
Expression and function of neurotrophins in medulloblastoma
A novel immunotherapeutic strategy for malignant glioma
Allelic variation in carcinogen metabolism and brain tumor risk
These are just a few of the advancements that we, together, have made happen. Our efforts on behalf of the thousands of people who are benefitting from our devotion to the cause is real. It’s genuine and it’s saving lives.
If you haven’t registered for the Boston Brain Tumor Ride the TIME IS NOW!!! Click the link and get on board. While you’re at it, grab a friend and let’s grow this ride to the level that we know it can be! Together we will pedal to turn progress into promise
For Michael Corkin and myself, Co-Chairs, Boston Brain Tumor Ride, and our entire Ride Committee,
May 2018 bring an end to brain tumors.
Love to all,
Co-Chairs, 2018 Boston Brain Tumor Ride Steven Branfman and Michael Corkin